3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
10
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Melanoma
8
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Eunuchism
1
Erectile Dysfunction
1
Interventions
Thyroidectomy
5
Iodine-131
5
Surgical Procedures, Operative
3
selpercatinib
2
lenvatinib
2
anlotinib
2
Ultrasonography
2
Transurethral Resection of Prostate
2
Sorafenib
2
Molecular Diagnostic Techniques
2
Interviews as Topic
2
Focus Groups
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
dabrafenib
1
Triiodothyronine
1
Thyroxine
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Routinely Collected Health Data
1
Radiotherapy, Adjuvant
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nivolumab
1
Minimally Invasive Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Thyroid Neoplasms
×
dabrafenib
×
Clear all
NCT07419932
2026-02-19
NeoLATC
Fujian Medical University
Recruiting
120 enrolled